Yungjin Pharm. Co., Ltd.
KSC: 003520.KS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Korea Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- GiSu Lee
- Employees
- 574
- Headquarters
- Seoul, South Korea
- IPO year
- 2001
- Market cap
- ₩303.8B
- Website
- https://www.yungjin.co.kr
Loading 003520…
Loading profile data…Frequently asked questions about 003520
What does Yungjin Pharm. Co., Ltd. (003520.KS) do?
Yungjin Pharm. Co., Ltd. operates as a pharmaceutical company in South Korea. It provides cephalosporin antibiotic, antipsychotic, cardiovascular, and nutrition products. The company was founded in 1952 and is headquartered in Seoul, South Korea. Yungjin Pharm. Co., Ltd. is a subsidiary of KT&G Corporation.
Where does 003520.KS trade?
Yungjin Pharm. Co., Ltd. (003520.KS) trades on the Korea Exchange.
What sector is 003520.KS in?
Yungjin Pharm. Co., Ltd. (003520.KS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Yungjin Pharm. Co., Ltd.?
GiSu Lee is the chief executive officer of Yungjin Pharm. Co., Ltd. (003520.KS).
Where is Yungjin Pharm. Co., Ltd. headquartered?
Yungjin Pharm. Co., Ltd. is headquartered in South Korea.
Does 003520.KS pay a dividend?
Yungjin Pharm. Co., Ltd. (003520.KS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 003520.KS go public?
Yungjin Pharm. Co., Ltd. (003520.KS) completed its initial public offering in 2001.